S&P 500
(0.27%) 5 475.09 points
Dow Jones
(0.13%) 39 170 points
Nasdaq
(0.83%) 17 879 points
Oil
(0.05%) $83.42
Gas
(0.20%) $2.48
Gold
(0.12%) $2 341.70
Silver
(0.46%) $29.75
Platinum
(1.44%) $992.40
USD/EUR
(0.05%) $0.931
USD/NOK
(0.17%) $10.67
USD/GBP
(0.03%) $0.791
USD/RUB
(0.00%) $86.75

Realtime updates for POINT Biopharma Global [PNT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated26 Dec 2023 @ 16:00

0.16% $ 12.50

Live Chart Being Loaded With Signals

Commentary (26 Dec 2023 @ 16:00):
Profile picture for POINT Biopharma Global Inc.

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors...

Stats
Today's Volume 3.29M
Average Volume 3.85M
Market Cap 1.33B
EPS $-0.230 ( Q3 | 2023-11-13 )
Next earnings date ( $0 ) 2024-08-12
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 11.36
(Sector) 42.63
(Industry) 24.32
ATR14 $0.322 (2.58%)
AADI -2.74%
ABCL -6.08%
ABCM 0.04%
ABEO -0.94%
ABIO -0.78%
ABOS -1.45%
ABSI -2.27%
ABUS 0.97%
ABVX 2.57%
ACAD -1.29%
ACER -17.95%
ACET -4.96%
ACGN 1.29%
ACHL -1.60%
ACHV 1.70%
ACIU -0.25%
ACLX -2.88%
ACRV 1.03%
ACST -2.34%
ACXP -4.89%
ADAG -0.33%
ADAP 7.70%
ADGI 0.87%
ADIL -5.22%
ADMA 3.31%
ADPT -0.55%
ADTX 14.49%
ADVM 1.60%
ADXN -12.26%
AEON -0.95%
AEZS 3.07%
AFMD -0.73%
AGEN -0.36%
AGIO 0.60%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -2.51%
AKRO -1.28%
AKTX 15.23%
AKUS 0.00%
ALBO 0.00%
ALDX -1.81%
ALEC -2.64%
ALGS 5.43%
ALKS 1.20%
ALLK -12.02%
ALLO 0.00%
ALLR 6.44%
ALNA 3.16%
ALNY 0.13%
ALPN 0.02%
ALPX 0.00%
ALRN 1.08%
ALT 8.27%
ALVR 0.93%
ALXN 0.00%
ALXO -0.66%
ALZN 0.91%
AMRN -0.29%
AMTI -3.13%
ANAB -1.80%
ANEB -1.83%
ANGN 0.00%
ANIX 0.45%
ANL -6.05%
ANNX 3.06%
ANPC -3.15%
APGE -1.96%
APGN 8.48%
APGNW 30.65%
APLM 0.96%
APLS -5.40%
APLT -1.28%
APM -7.51%
APOP 0.38%
APRE -0.98%
APTO -1.51%
APTX 3.17%
APVO 9.15%
ARAV -13.39%
ARCT -2.83%
ARDS 19.76%
ARDX 2.16%
ARGX 0.97%
ARNA 0.00%
ARPO -0.90%
ARQT 2.80%
ARTL -3.57%
ARTLW 0.00%
ARVN -2.40%
ARWR 0.23%
ASLN 0.00%
ASMB -3.50%
ASND -1.76%
ATAI 1.50%
ATHA -5.28%
ATHE 0.00%
ATHX -33.50%
ATNF -7.98%
ATOS 0.84%
ATRA -1.65%
ATXI -2.86%
ATXS 1.65%
AUPH -3.85%
AURA -2.51%
AUTL -0.29%
AVBP -2.16%
AVEO 0.00%
AVIR 1.81%
AVRO -1.41%
AVTE 2.41%
AVTX 1.12%
AVXL -2.61%
AXLA 0.00%
AXSM 0.66%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -0.51%
BCAB -1.46%
BCDA 0.67%
BCDAW 0.00%
BCEL 0.00%
BCLI 5.47%
BCRX 7.93%
BCTX -4.39%
BCTXW 17.17%
BCYC 0.25%
BDRX -0.23%
BDTX 0.86%
BEAM -1.62%
BFRA -2.91%
BGNE 1.56%
BIOR -4.56%
BIVI 4.00%
BLCM -6.68%
BLI -5.88%
BLPH -1.93%
BLRX -1.06%
BLTE 0.31%
BLU 0.03%
BLUE -0.90%
BMEA -1.78%
BMRN -0.24%
BNOX -10.04%
BNTC 3.92%
BNTX -1.90%
BOLD 8.27%
BOLT -2.41%
BPMC 1.30%
BPTH -3.00%
BPTS -13.47%
BRNS 2.14%
BRTX -2.46%
BTAI -8.59%
BTTX -15.97%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 2.92%
CABA 4.41%
CADL 1.61%
CALA 0.00%
CALC 7.32%
CALT -0.62%
CAPR 1.47%
CARA 1.94%
CARM 9.87%
CASI -1.82%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -5.89%
CCCC 4.98%
CCXI 0.00%
CDAK 0.00%
CDIO -1.82%
CDIOW 6.00%
CDMO -0.28%
CDMOP 0.04%
CDT -6.12%
CDTTW 72.08%
CDTX 0.84%
CDXC -1.47%
CDXS -3.55%
CELC 1.59%
CELU 1.92%
CELUW 1.32%
CERC -1.68%
CERE 1.13%
CERO -8.16%
CEROW 43.57%
CFRX -27.95%
CGEM -4.07%
CGEN 4.17%
CGON 0.48%
CGTX 0.60%
CHMA -6.00%
CHRS -6.94%
CINC 0.00%
CING 7.50%
CINGW 4.85%
CKPT -4.65%
CLBS -16.75%
CLDX 5.35%
CLGN 1.00%
CLLS 3.48%
CLNN 0.22%
CLNNW 44.05%
CLRB 2.00%
CLSD -4.62%
CLSN -0.68%
CLVS 0.00%
CMMB 5.00%
CMND -1.19%
CMPI 0.00%
CMPX -5.45%
CMRA 0.00%
CMRAW 33.33%
CMRX -0.80%
CNCE 0.00%
CNSP -10.13%
CNST 0.00%
CNTA -2.55%
CNTB -5.26%
CNTX -9.73%
COCP 3.00%
COEPW 0.00%
COGT 6.05%
CORT 0.55%
COYA 0.66%
CPRX 1.81%
CRBP 9.17%
CRBU -3.05%
CRDF -7.66%
CRGX -2.56%
CRIS -7.54%
CRNX 2.86%
CRSP -0.11%
CRTX 2.63%
CRVO -5.84%
CRVS 1.65%
CSBR -4.26%
CTCX 23.31%
CTIC 0.06%
CTMX 9.02%
CTNM 19.25%
CTXR -6.92%
CUE -17.74%
CVAC -2.06%
CVKD -1.15%
CWBR 0.00%
CYAD -12.96%
CYCC 0.00%
CYCCP -11.68%
CYCN 0.88%
CYT -2.27%
CYTK 0.96%
CYTO 9.91%
DARE -6.03%
DAWN -1.45%
DBTX -0.81%
DBVT 2.20%
DFFN 10.28%
DICE 0.06%
DMAC 0.00%
DNLI -5.21%
DNTH 11.55%
DOMH 4.81%
DRMA -5.37%
DRMAW 7.69%
DRNA 0.00%
DRTS 0.79%
DRTSW 19.05%
DRUG -2.77%
DSGN -2.99%
DTIL 1.64%
DYAI 3.38%
EARS -1.77%
EDIT -1.28%
EDSA 2.09%
EFTR -8.00%
EFTRW -41.67%
EIGR -9.21%
ELAB 0.07%
ELDN -4.92%
ELEV 5.93%
ELOX 1.45%
ELTX -8.03%
ELVN -2.87%
ELYM -0.84%
ENGN -4.03%
ENGNW -2.88%
ENLV -2.82%
ENOB 1.79%
ENSC -1.23%
ENTA 0.77%
ENTO -11.11%
ENTX -4.35%
ENVB -5.90%
EPIX -2.66%
EPRX 2.38%
EPZM 0.00%
EQ -2.21%
EQRX -2.09%
EQRXW 0.00%
ERAS 3.39%
ERNA 4.14%
ERYP 1.30%
ESLA 4.76%
ESLAW 0.00%
ETNB -3.12%
ETON 3.34%
ETTX 0.00%
EVAX 0.70%
EVGN -0.91%
EVLO 39 899.32%
EWTX 7.61%
EXAI 0.98%
EXEL -0.98%
EYEG -0.51%
EYEN 14.27%
EYPT -4.48%
FATE -0.61%
FBIO -1.17%
FBIOP 0.70%
FBLG -19.84%
FBRX 1.68%
FDMT 1.67%
FENC 2.62%
FGEN -13.69%
FHTX 1.57%
FIXX 0.77%
FMTX 0.00%
FNCH -10.95%
FOLD -1.21%
FREQ 4.76%
FRLN 0.15%
FRTX -4.21%
FSTX 0.00%
FTRE 2.23%
FULC 1.77%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 3.98%
GANX -12.50%
GBIO -8.87%
GBT 0.01%
GDTC -0.99%
GERN 2.36%
GHRS 0.77%
GLMD -1.01%
GLPG 0.93%
GLSI -2.84%
GLTO -1.73%
GLUE 5.35%
GLYC 5.15%
GMAB -1.11%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT 10.80%
GNLX -5.64%
GNPX 2.39%
GNTA -0.87%
GOSS 5.18%
GOVX 2.98%
GOVXW -10.37%
GPCR 1.86%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -6.13%
GRTX -8.63%
GTHX 8.33%
GUTS 4.45%
GXGXW 41.67%
GYRE 0.92%
HALO -0.65%
HARP 0.09%
HCWB 0.46%
HEPA -0.93%
HGEN -84.62%
HILS 5.66%
HLVX -0.28%
HOOK 6.17%
HOTH -1.12%
HOWL -3.69%
HRMY 0.83%
HRTX -0.86%
HSTO 0.00%
HUMA 11.88%
HUMAW 22.30%
IBRX -0.79%
ICCC -8.04%
ICPT 0.21%
ICU 23.06%
ICUCW 13.26%
ICVX -0.91%
IDRA -23.04%
IDYA 2.31%
IFRX -1.72%
IGMS -1.16%
IKNA 0.00%
IKT -5.34%
IMAB -2.99%
IMCR 7.49%
IMGN 0.02%
IMGO 0.00%
IMMP 0.00%
IMMX 7.07%
IMNM 0.83%
IMNN 8.62%
IMPL -27.27%
IMRA 15.96%
IMRN -9.26%
IMRX -8.59%
IMTX 3.27%
IMTXW 27.41%
IMUX 0.90%
IMV 0.00%
IMVT 4.20%
INAB -3.95%
INBX -3.03%
INCY 0.41%
INDP 4.25%
INFI -52.38%
INKT -3.51%
INM -5.24%
INMB -4.54%
INO 6.56%
INSM -0.99%
INTS 0.41%
INVA 0.61%
INZY -1.12%
IOBT -4.27%
IONS -1.15%
IOVA 0.50%
IPA -3.71%
IPHA 7.22%
IPSC -5.49%
IRON 3.11%
ISEE 0.38%
ITOS 1.15%
ITRM -5.60%
IVA -1.19%
IVVD 9.09%
JAGX -2.79%
JANX -0.41%
JAZZ -0.24%
JNCE 0.00%
JSPR 1.94%
JSPRW 5.15%
JUNS 0.00%
JUNSW 0.00%
KA 4.20%
KALV 0.93%
KDNY 0.22%
KMPH -0.34%
KNSA -3.59%
KNTE -0.38%
KOD 0.85%
KPRX 3.57%
KPTI -6.01%
KRBP -1.83%
KRON -9.68%
KROS -4.22%
KRRO -0.06%
KRTX 0.03%
KRYS -0.75%
KTRA 10.14%
KTTA 0.38%
KTTAW 1.83%
KURA 2.96%
KYMR 3.69%
KYTX 4.13%
KZIA -4.91%
KZR -2.73%
LABP 0.57%
LBPH 14.39%
LBPS 0.00%
LBPSW 14.81%
LEGN 3.91%
LENZ 2.31%
LEXX -0.72%
LEXXW 23.90%
LGND 0.70%
LGNDV 0.00%
LGVN -2.48%
LIAN -8.28%
LIFE 2.70%
LIPO -3.41%
LIXT -0.38%
LIXTW -3.71%
LJPC -0.32%
LMNL 0.12%
LOGC -3.15%
LPCN -6.31%
LPTX -4.59%
LQDA 0.33%
LRMR 13.66%
LSTA 2.31%
LTRN -3.21%
LUMO -2.46%
LVTX 3.89%
LXEO -2.68%
LXRX -0.30%
LYEL 8.97%
LYRA 7.30%
MACK 0.10%
MBIO 2.41%
MBRX -1.15%
MCRB -0.25%
MDGL -0.30%
MDNA -13.16%
MDWD -0.84%
MDXG -3.32%
MEIP -2.06%
MESO -0.44%
MGNX 1.18%
MGTA -7.74%
MGTX -2.61%
MGX 8.33%
MIRM -0.09%
MIRO 0.59%
MIST 0.75%
MITO 0.00%
MLEC -0.88%
MLECW -31.50%
MLND -5.36%
MLTX -4.94%
MLYS 4.02%
MNKD -2.49%
MNMD -1.94%
MNOV 0.00%
MNPR -0.88%
MOLN 2.80%
MOR -0.22%
MORF -4.46%
MREO 0.83%
MRKR -0.74%
MRNA -2.36%
MRNS 9.40%
MRSN -1.99%
MRTX -0.17%
MRUS -7.98%
MRVI -3.07%
MTCR -1.29%
MTEM 2.61%
MTP -18.50%
MURA -0.96%
MYMD 0.00%
NAMS 7.13%
NAMSW -4.76%
NAUT -2.99%
NBRV 0.71%
NBSE -1.56%
NBTX 7.00%
NCNA 7.36%
NERV -0.86%
NEXI -6.90%
NGM -1.28%
NGNE 11.62%
NKGN 0.00%
NKGNW -12.00%
NKTR -1.61%
NKTX -1.02%
NLSP -9.50%
NLSPW 26.58%
NMRA 1.12%
NMTR -42.97%
NOVN -24.84%
NRBO -6.20%
NRIX 0.19%
NRSN -3.57%
NRSNW -2.91%
NRXP 5.74%
NRXPW 41.43%
NRXS 1.44%
NTBL -6.12%
NTEC -12.45%
NTHI 0.00%
NTLA 0.40%
NTRBW 74.65%
NUVL -0.46%
NVAX 0.55%
NVCT -2.37%
NVIV -34.28%
NXTC -5.66%
NYMX -0.05%
OABI -0.27%
OABIW -9.28%
OBIO -12.64%
OBSV 0.00%
OCEA -3.28%
OCGN 4.84%
OCS -0.50%
OCUL -2.63%
OCUP 3.92%
ODT -4.27%
OKYO 1.64%
OLMA 2.96%
OMER -2.71%
OMGA 8.70%
ONCO -6.10%
ONCR -3.08%
ONCS 31.87%
ONCT -7.70%
ONCY 0.53%
ONTX -0.47%
ONVO -0.34%
OPNT 0.00%
OPT -0.99%
ORGS 8.13%
ORIC 8.06%
ORMP -0.39%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK 0.41%
OVID 12.09%
OYST 0.00%
PALI -5.29%
PASG 11.43%
PBLA -10.00%
PBM 6.33%
PBYI 0.61%
PCSA -7.11%
PCVX 1.89%
PDSB 3.41%
PEPG 12.22%
PGEN -1.90%
PHAR -4.62%
PHAS 0.00%
PHAT 4.95%
PHIO -3.88%
PHIOW 36.47%
PHVS -0.59%
PHXM -5.20%
PIRS -1.82%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 1.02%
PLUR -0.43%
PMN 6.67%
PMVP -2.47%
PNT 0.16%
PPBT -13.47%
PRAX -0.41%
PRDS 0.93%
PRLD -1.05%
PROG -3.47%
PROK 1.63%
PRQR -0.60%
PRTA -0.78%
PRTC 3.68%
PRTG -7.63%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV 2.04%
PSTX 3.08%
PTCT 1.93%
PTE -0.82%
PTGX 1.59%
PTIXW -48.41%
PULM 1.55%
PXMD -1.27%
PYPD -0.24%
PYXS -3.32%
QLGN -3.77%
QNCX -3.33%
QNRX 1.75%
QSI -11.01%
QSIAW 4.08%
QTTB 5.74%
QURE -0.78%
RAIN -1.63%
RANI 0.53%
RAPT -5.57%
RARE 0.05%
RCKT -4.04%
REGN 0.57%
RENB -10.86%
REPL 4.00%
RETA 0.02%
REUN -0.89%
REVB -1.58%
REVBU 3.46%
REVBW 0.00%
RGLS 6.44%
RGNX -5.38%
RIGL 2.31%
RLAY -1.84%
RLMD 2.33%
RLYB 1.49%
RNA 1.05%
RNAC -10.14%
RNAZ -4.54%
RNXT 1.77%
ROIV 2.46%
ROIVW 4.56%
RPHM 2.65%
RPRX -0.68%
RPTX 0.91%
RUBY 2.70%
RVLP -32.05%
RVMD 0.00%
RVMDW -1.40%
RVNC 0.00%
RVPH -7.03%
RVPHW 4.88%
RXDX 0.09%
RXRX -0.53%
RYTM 3.92%
RYZB 0.02%
RZLT 0.23%
SABS -1.94%
SABSW 54.57%
SAGE 1.57%
SANA 0.18%
SAVA -1.70%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 3.16%
SCPH -0.69%
SCPS 0.00%
SEEL 3.69%
SEER 0.60%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -7.90%
SGMT -7.60%
SGTX -2.56%
SIOX 22.63%
SLDB 10.58%
SLGL -4.21%
SLN -1.37%
SLNO 3.65%
SLRX -7.92%
SLS -0.84%
SMMT 4.36%
SNDX 4.87%
SNGX -4.26%
SNPX 1.97%
SONN -0.80%
SPPI -0.49%
SPRB 2.55%
SPRC -5.98%
SPRO -1.54%
SRNE -20.00%
SRPT -0.79%
SRRA 0.00%
SRRK -2.40%
SRZN -2.28%
STAB 0.00%
STOK 2.66%
STRO 4.10%
STSA 0.00%
STTK 3.37%
SURF -0.93%
SVRA 15.14%
SWTX 2.28%
SYBX -0.67%
SYRS -4.46%
TALS -0.73%
TARA 0.48%
TARS 3.90%
TBPH 0.47%
TCBP 1.76%
TCDA 0.00%
TCON -30.63%
TCRR 0.00%
TCRT -6.87%
TCRX 1.37%
TECH -0.06%
TENX -1.32%
TERN 0.59%
TFFP 7.23%
TGTX 2.02%
THRX 0.12%
TIL 0.10%
TLC 0.00%
TLSA -3.63%
TNGX 4.90%
TNXP 4.96%
TNYA 8.71%
TPST -2.28%
TRDA 0.49%
TRVI -3.02%
TRVN -3.81%
TSHA 0.89%
TSVT 5.19%
TTNP -0.18%
TVTX 0.73%
TYRA 8.07%
UBX -1.48%
UNCY 7.76%
URGN -1.79%
UTHR 0.14%
VACC 11.36%
VALN -3.27%
VAXX 20.24%
VBIV 4.85%
VBLT -8.77%
VCEL -1.85%
VCNX -0.15%
VCYT -1.57%
VERA 0.30%
VERU 4.45%
VERV 2.05%
VIGL 9.25%
VINC -6.26%
VIR 2.25%
VIRI 3.26%
VIRX -6.20%
VKTX 4.36%
VLON -13.04%
VNDA -1.24%
VOR -1.07%
VRCA 9.05%
VRDN 1.54%
VRNA 7.26%
VRPX -1.59%
VRTX 0.54%
VSTM 9.06%
VTGN 2.59%
VTVT -0.42%
VTYX -2.16%
VXRT 3.19%
VYGR -0.63%
VYNE -2.54%
VYNT 7.78%
WINT 0.00%
WVE 4.91%
XBIO -0.48%
XBIT 7.98%
XCUR -3.93%
XENE -3.33%
XERS -3.56%
XFOR 1.62%
XLO -2.49%
XLRN 0.00%
XNCR 0.48%
XOMA 5.11%
XOMAO 0.20%
XOMAP 1.98%
XRTX -1.06%
YMAB -2.07%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -0.23%
ZNTL 2.45%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-12-26 Goodman Jonathan R. Sell 41 872 Common Stock
2023-12-27 Goodman Jonathan R. Sell 35 872 Stock Option (Right to Buy)
2023-12-27 Goodman Jonathan R. Sell 25 000 Stock Option (Right to Buy)
2023-12-27 Goodman Jonathan R. Sell 25 614 Stock Option (Right to Buy)
2023-12-27 Goodman Jonathan R. Sell 44 749 Stock Option (Right to Buy)
INSIDER POWER
-79.76
Last 96 transactions
Buy: 3 517 450 | Sell: 10 366 533

Volume Correlation

Long: 0.24 (neutral)
Short: -0.64 (weak negative)
Signal:(35.382) Neutral

POINT Biopharma Global Correlation

10 Most Positive Correlations
LVOX0.847
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

POINT Biopharma Global Correlation - Currency/Commodity

The country flag -0.15
( neutral )
The country flag -0.22
( neutral )
The country flag -0.67
( moderate negative )
The country flag 0.47
( neutral )
The country flag 0.88
( strong )
The country flag 0.26
( neutral )

POINT Biopharma Global Financials

Annual 2022
Revenue: $226.58M
Gross Profit: $226.58M (100.00 %)
EPS: $1.040
FY 2022
Revenue: $226.58M
Gross Profit: $226.58M (100.00 %)
EPS: $1.040
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.181
FY 2020
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.00801

Financial Reports:

No articles found.

POINT Biopharma Global Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

POINT Biopharma Global

POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast activation protein-a targeting program being developed for use in multiple tumor types that is under preclinical studies. In addition, it has product candidates being developed on CanSEEK technology sub-licensed from both Bach Biosciences LLC and Avacta Life Sciences Limited. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 6.250168800354 seconds
Number of API calls: 3
Number of DB calls: 9